Applied Finance Capital Management, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1966007 SAN JUAN, PR

Position in GILD

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$1,856,313

-$971,086 QoQ

Shares Held

14,693

-27.6% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

#858

of 2,266 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Applied Finance Capital Management, LLC holds $53,647,387 across 10 Drug Manufacturers - General names. GILD ranks #7 (3.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	133,454	$17,148,839
2	LLY	ELI LILLY & Co	12,549	$15,051,648
3	JNJ	Johnson & Johnson	25,604	$6,502,647
4	ABBV	AbbVie Inc.	25,128	$6,323,209
5	AMGN	Amgen Inc	6,845	$2,478,711
6	BMY	Bristol Myers Squibb Co	35,950	$2,071,439
7	GILD	Gilead Sciences, Inc. This page	14,693	$1,856,313
8	NVS	Novartis AG	6,260	$981,067

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,856,313	14,693	-27.6%	Shares	Sole	2026-07-28
2026-03-31	$2,827,399	20,287	-3.6%	Shares	Sole	2026-05-04
2025-12-31	$2,582,940	21,044	+39.9%	Shares	Sole	2026-02-05
2025-09-30	$1,669,440	15,040	-6.6%	Shares	Sole	2025-11-06
2025-06-30	$1,784,563	16,096	-29.0%	Shares	Sole	2025-07-29
2025-03-31	$2,539,053	22,660	-2.1%	Shares	Sole	2025-05-07
2024-12-31	$2,137,349	23,139	-5.5%	Shares	Sole	2025-02-13
2024-09-30	$2,052,570	24,482	+7.5%	Shares	Sole	2024-11-08
2024-06-30	$1,562,112	22,768	—	Shares	Sole	2024-07-31
No filing history on record for this holder in this stock.